pH-sensitive polymeric nanoparticles with antioxidant and anti-inflammatory properties against cisplatin-induced hearing loss-Reference-Cited by-同舟云学术

pH-sensitive polymeric nanoparticles with antioxidant and anti-inflammatory properties against cisplatin-induced hearing loss

Published:2018-01 Issue: Volume:270 Page:53-64
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Martín-Saldaña Sergio,Palao-Suay Raquel,Aguilar María Rosa^ORCID,García-Fernández Luis,Arévalo Humberto^ORCID,Trinidad Almudena,Ramírez-Camacho Rafael,San Román Julio

Funder

Spanish Ministry of Economy and Competitiveness

CIBER BBN-ECO

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference60 articles.

1. Nanomedicine strategies for drug delivery to the ear;Pritz;Nanomedicine,2013

2. Otoprotective properties of 6α-methylprednisolone-loaded nanoparticles against cisplatin: in vitro and in vivo correlation;Martín-Saldaña;Nanomedicine,2016

3. Tailor-made dual pH-sensitive polymer–doxorubicin nanoparticles for efficient anticancer drug delivery;Du;J. Am. Chem. Soc.,2011

4. Smart polymers for responsive drug-delivery systems;Traitel;J. Biomater. Sci. Polym. Ed.,2008

5. Smart Polymers and their Applications;Aguilar,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probucol-Ursodeoxycholic Acid Otic Formulations: Stability and In Vitro Assessments for Hearing Loss Treatment;Journal of Pharmaceutical Sciences;2024-08

2. Hyaluronic acid-ibuprofen conjugation: a novel ototherapeutic approach protecting inner ear cells from inflammation-mediated damage;Frontiers in Pharmacology;2024-02-15

3. Harnessing astaxanthin-loaded diselenium cross-linked apotransferrin nanoparticles for the treatment of secretory otitis media;Journal of Controlled Release;2024-01

4. The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles;Environmental Research;2024-01

5. Controlled release of dexamethasone from fibrin sealant for intratympanic administration in inner ear therapy;Journal of Otology;2024-01